Alex is one of the world’s leading experts at the intersection of health and technology. For the last 15 years he has lead the digital transformation of healthcare, both from within the industry at Johnson & Johnson and servicing the industry by founding and leading multiple award-winning agencies. Most recently he co-founded Foundry3 which houses the world's first digital health innovation Lab focussed on the pharmaceutical industry, the ‘Innovation Foundry’. Alex pioneered the application and integration of new philosophies and technologies within pharma, launching the first digital only marketing campaign supporting a pharmaceutical brand, he was the first to utilise social media and he commissioned and designed mobile health applications before the advent of the app store. This led to numerous digital marketing and communications awards, the inaugural recipient of the Global Social Media Pioneer award in Philadelphia in 2010 followed by the James E Burke Marketing Award for Uncommon Courage in 2011, the first pharma professional recipient. He has won over 30 PM Digital awards and the prestigious AXA PPP Global Health Technology Award 2017 with his work displayed in the Design Museum in London. Alex has been the brain child of ground breaking digital health solutions in respiratory disease, Pulmonary Arterial Hypertension, transplantation, opioid addiction, MS, diabetes and psoriasis among others. He is also an invited member of the Wharton Global Advisory Board on the Future of Advertising and a Fellow of the Chartered Institute of Marketing (FCIM).
In late December 1516, the English lawyer, social philosopher, author, statesman and noted Renaissance humanist (and future catholic saint), Thomas More, published Utopia, a book about an ideal society on an imaginary island in an unknown place faraway across the seas. Even 500 years later it stirs debate as to whether this is some kind of comment or criticism of contemporary European society, blueprint for socialist philosophy, the first work of science fiction or more simply a clever farce. Or perhaps a combination, in some way, of all of these things.
Patient centricity is a central philosophy and strategy for virtually all of the top 40 global pharmaceutical companies. What this means and how to achieve it, however, varies considerably.
Digital health should not be inspired by technology but by great people like Wendy Mitchell. When listening to health tech or innovation presentations they often use quotes by the likes of Steve Jobs, Reed Hastings who started Netflix, Joe Gebbia & Brian Chesky who started Airbnb or some other disruptive technology entrepreneur. However, we must never forget to have great people like Wendy Mitchell as our driving force, understand their lives, their hopes and fears and their everyday problems. Unsurprisingly this goes well beyond taking their medicine.
The emphasis and importance placed on innovation in the pharmaceutical industry has risen dramatically over the last 5 years. Although successful in bringing innovative medicines to the market, it has been much harder to bring that innovation mind-set to other functions of the pharmaceutical industry in the way they communicate with customers, augment a medicines value proposition and utilise innovative technology to improve both clinical and patient outcomes. This however is changing fast.
Healthcare professionals, scientists and pharmaceutical companies’ understanding of the daily impact of disease and treatment on a person’s life are not always as good as they could be. Historically the focus has been on clinical outcomes, with an assumption that this naturally aligns with the outcomes from a patient’s perspective. Unfortunately, they are not always aligned at all.